Literature DB >> 19473091

Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe.

Kirsty England, Claire Thorne.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19473091      PMCID： PMC3428872          DOI： 10.1086/599230

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

1.  Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

Authors: 
Journal:  HIV Clin Trials       Date:  2001 Jan-Feb

2.  A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.

Authors:  Glenda E Gray; Michael Urban; Matthew F Chersich; Carolyn Bolton; Ronelle van Niekerk; Avy Violari; Wendy Stevens; James A McIntyre
Journal:  AIDS       Date:  2005-08-12       Impact factor: 4.177

3.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Authors:  Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

4.  Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.

Authors:  Taha E Taha; Newton I Kumwenda; Amanda Gibbons; Robin L Broadhead; Susan Fiscus; Valentino Lema; George Liomba; Chiwawa Nkhoma; Paolo G Miotti; Donald R Hoover
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

5.  Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Authors:  Josiane Warszawski; Roland Tubiana; Jerome Le Chenadec; Stephane Blanche; Jean-Paul Teglas; Catherine Dollfus; Albert Faye; Marianne Burgard; Christine Rouzioux; Laurent Mandelbrot
Journal:  AIDS       Date:  2008-01-11       Impact factor: 4.177

6.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

7.  British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008.

Authors:  A de Ruiter; D Mercey; J Anderson; R Chakraborty; P Clayden; G Foster; C Gilling-Smith; D Hawkins; N Low-Beer; H Lyall; S O'Shea; Z Penn; J Short; R Smith; S Sonecha; P Tookey; C Wood; G Taylor
Journal:  HIV Med       Date:  2008-08       Impact factor: 3.180

8.  Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.

Authors:  N A Wade; G S Birkhead; B L Warren; T T Charbonneau; P T French; L Wang; J B Baum; J M Tesoriero; R Savicki
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245

Review 9.  Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Authors:  Claire Thorne; Marie-Louise Newell
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

10.  The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West.

Authors: 
Journal:  AIDS       Date:  2006-06-26       Impact factor: 4.177
  10 in total
  3 in total

1.  In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.

Authors:  Raymond Griner; Paige L Williams; Jennifer S Read; George R Seage; Marilyn Crain; Ram Yogev; Rohan Hazra; Kenneth Rich
Journal:  AIDS Patient Care STDS       Date:  2011-06-10       Impact factor: 5.078

2.  Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015.

Authors:  Paige L Williams; Yanling Huo; Richard Rutstein; Rohan Hazra; Kathryn Rough; Russell B Van Dyke; Ellen G Chadwick
Journal:  AIDS Patient Care STDS       Date:  2018-02       Impact factor: 5.078

3.  Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.

Authors:  Jennifer Neubert; Maren Pfeffer; Arndt Borkhardt; Tim Niehues; Ortwin Adams; Mareike Bolten; Stefan Reuter; Hans Stannigel; Hans-Juergen Laws
Journal:  BMC Pregnancy Childbirth       Date:  2013-01-24       Impact factor: 3.007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.